With DCGI Nod in hand, Roche launches Breast Cancer Drug Atezolizumab in India Medical Dialogues Bureau9 April 2020 7:00 AM GMTNew Delhi: Drug firm Roche India on Wednesday said it has launched immunotherapy drug Atezolizumab for the treatment of metastatic triple-negative brea...
Roche Venclexta/Venclyxto combination shows promising results in phase III VIALE-A study in Leukemia patients Medical Dialogues Bureau29 March 2020 6:45 AM GMTVenclexta/Venclyxto is being developed by AbbVie and Roche.
Genentech,BARDA gets USFDA nod for Actemra Clinical Trial in COVID-19 patients Medical Dialogues Bureau28 March 2020 4:45 AM GMTUS: Genentech, a member of the Roche Group has announced the U.S. Food & Drug Administration (FDA) has approved a randomized, double-blind,...
Roche begins Phase III clinical trial of Actemra in hospitalised patients with severe COVID-19 pneumonia Medical Dialogues Bureau20 March 2020 4:30 AM GMTBasel: Roche has announced that it is working with the Food & Drug Administration (FDA) to initiate a randomised, double-blind, placebo-controlled ...
Roche Diagnostics India first private firm to get COVID-19 test approval Medical Dialogues Bureau20 March 2020 4:30 AM GMTNew Delhi: Roche Diagnostics India has received the license from the country's drug regulator DCGI for its ''Cobas SARS CoV-2'' diagnostic test kit, ma...
Roche gets USFDA Emergency Use Authorization for its Cobas SARS-CoV-2 Test Medical Dialogues Bureau15 March 2020 7:19 AM GMTBasel: Roche has announced that the U.S. Food and Drug Administration (FDA) has issued an Emergency Use Authorization (EUA) for the cobas® SARS-CoV-2 T...
Roche gets USFDA nod for CINtec PLUS Cytology test for cervical cancer Medical Dialogues Bureau12 March 2020 6:42 AM GMTCINtec PLUS Cytology provides definitive information about which HPV-positive women may benefit most from immediate referral to colposcopy versus...
